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CD44 is a group of cell surface glycoproteins that is 
generated from a single gene by mRNA splice varia-
tion. Its functions in matrix adhesion and tumor 
invasion are strongly influenced by glycosylation. We 
studied the glycosylated tissue forms of CD44 from 
extracts of normal adult human epidermis by using 
western blotting and immunoprecipitation from 
short-term skin organ cultures. An antibody for 
CD44 (Hermes 3) precipitated 7-17% of all 35S04 -
labeled proteoglycans (PGs) synthesized in epider-
mis. Immunoprecipitates digested with heparitinase 
lost 40-68% of incorporated 35S04 and 24-40% of 
[ 3H]glucosamine, indicating that heparan sulfate was 
the predominant glycosaminoglycan in epidermal 
CD44. Chondroitinase ABC released 10-25% and 
6-12% of 35S04 and [3H]glucosamine, respectively. 
Less than 5% of both isotopes were susceptible to 
keratanase. Five to 33% of 35S04 and 26-37% of 
[ 3H]glucosamine, however, was released by endo-/3-
galactosidase, implying marked substitution by oli-
gosaccharides with N-acetyllactosamine repeats. He-
H uman epidermis gives an intense signal with anti-bodies against CD44 (Wang eta/, 1992), an ubiq-uitous cell surface receptor glycoprotein (Picker et al, 1989). One of the ligands of CD44 is hyaluro-nan (Lesley et al, 1993) , which exists in ample 
quantlhes around epidermal keratinocytes (Tammi et a/, 1989, 
1994) and shows a close histologic co localization with CD44 
(Wang et a/, 1992). CD44 is known to organize hyaluronan-
dependent pedcellular mah;ces and coats on cells (Knudson, 1993) 
and may also function as an uptake receptor for hyaluronan (Culty 
eta/, 1992; Hua eta/, 1993). Although CD44 has a number of other 
ligands, including fibronectin Qalkanen and Jalkanen, 1992), col-
lagen types I and IV (Wayner and Carter, 1987; Carter and 
Wayner, 1988), chondroitin sulfate-modified invariant chain (Nau-
jokas et a/, 1993), serglycin (Toyama-Sorimachi and Miyasaka, 
1994), and osteopontin (Weber et al, 1996), they are not present in 
normal human epidermis . It is therefore likely that CD44 is 
associated with and plays an important role in the metabolism of 
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paritinase pretreatment retarded, whereas endo-/3-
galactosidase enhanced the mobility of the ;:::180-kDa 
polydisperse CD44 on agarose gel electrophoresis. 
On SDS-polyacrylamide gel electrophoresis, how-
ever, western blotting and :Buorographs of 35S04 -
labeled immunoprecipitates showed the main CD44 
isoform at ;:::250 kDa and a shift to 180-200 kDa after 
heparitinase treatment. Keratanase, keratanase II, 
and chondroitinase ABC had minor effects. A less 
abundant form of CD44, with a core of 100 kDa, 
pardy substituted with chondroitinase ABC- and endo-
/3-galactosidase-sensitive chains, was also present. 
Therefore, the large heparan sulfate-substituted 
CD44 forms a significant part of all proteoglycans in 
normal human epidermis. Both the large and the 
100-kDa variant of epidermal CD44 contain endo-/3-
galactosidase-sensitive oligosaccharides not previ-
ously noted in other cells or tissues. Key JVOI'ds: lunna.n 
skiu!cltottdroititt sulfatelkemtatt sulfa.te!ltyalm-ottau. J Invest 
Dentla.tol 109:213-218, 1997 
epidermal hyalw·onan, a glycosaminoglycan involved in the main-
tenance (Tanuni eta/, 1988), development (Agren eta/, 1997), and 
inflammation of epidermis (Tammi et nl, 1994), as well as in the 
malignant growth of stratified human epithelia (Wang et nl, 1996) . 
The "standard" CD44 (CD44s) expressed by most leukocytes 
has a calculated core protein size of 38 k:Da and is regttlarly 
substituted with about eight N-linked and four or five 0 -linked 
o ligosaccharides (Lokeshwar et a/, 1996), resulting in an apparent 
size of 80-100 k:Da in sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE). A chondroitin sulfate substitution ha~ 
also been found on some CD44s molecules Qalkanen andJalkanen, 
1992), increasing the apparent size to 180-200 k:Da. Higher 
rnolecular mass variants of CD44, with a caJcu.lated core protein 
size of up to 94.5 k:Da (Screaton et a/, 1992) and apparent mobility 
2:: 180 k:Da in SDS-PAGE, are expressed in several epithelia] tissues 
(Brown et a/, 1991; Mackay eta/, 1994). The high molecular weight 
variants often bear heparan sulfate chains (Haggerty et a/, 1992; 
Hudson eta/, 1995) on exon v3 Qackson eta/, 1995). Four potential 
sites for chondroitin sulfate substitution exist on nonvariant exons 
5, 6, and 7 and one site exists on the variant exon v10 of the human 
CD44 (Screaton et al, 1992). 
Albeit there is extensive Literature on CD44 expressed on blood 
cells and cells cultured on plastic, little data beyond immunohisto-
chemical staining exist for tissues in 11i11o. As a part of our interest in 
0022-202X/97 /Sl 0.50 • Copyright © 1997 by The Society for Investigative Dermatology, Inc. 
213 
214 TUHKANEN ET A L 
epidermal hyaluronan, we wanted to characterize the CD44 forms 
specific for normal human epidermis. T his was prompted by the 
fact that in various tissues, a number of diJferent proteins are 
produced by a lternative mRNA splicing fi:om a single CD44 gene 
(Screaton et al, 1992) and that further tissue- and cell-line-
dependent variation arises by multiple types of g lycosylation, which 
appear functionally important in cell adh esion and hyaluronan 
binding (Milstone e/ a/ , 1994; Hudson et a/, 1995; Bartolazzi e/ a/, 
1996; B ennett ef al, 1996; Takahashi et a/, 1996). Studies on 
cultured keratinocytes have revealed an exceptional pattern oflarge 
CD44 variants (Haggerty el a/ , 1992; Kugelman et a/ , 1992; 
Milstone et a/, 1994; Hudson et a/, 1995; Jackson el a/, 1995), the 
most abundant including exons v3-v10 (epican) (Kugelman et a/, 
1992; Hudson et a/ , 1995) . 
Culturing cells as monolayers may modify the expression of cell 
surface adhesion molecules like CD44. In the c urrent study, we 
characterized the CD44 in adult human epidermis, a tissue w ith 
keratinocytes as the dominant cell type, by using western blotting 
and metabolic labeling in short-term organ culture (Tammi, 1981; 
Tammi and Santti, 1982). The results indicate that normal epider-
nus expresses a high molecular mass ( ;;::250 kDa) CD44 as one of its 
major heparan sulfate proteoglycans. Relatively less of 100-kDa 
CD44 was present, w ith a portion containing chondroitin sulfate. A 
h eavy substitution with polylactosamine-type oligosaccharides sen-
sitive to endo-,13-galactosidase was a novel feature of human 
epidermal CD44. 
MATEIUALS AND METHODS 
Skin Organ Culture Adult human skin was obtained from patients 
undergoing mastectomy operations, with the consent of The Ethical 
Committee of the University Hospital in Kuopio. Explants were cultured 
under chemically defined conditions according to the method described 
earlier (Tammi and Jansen, 1980). The culture medium used was Eagle's 
minimum essential medium (Flow Laboratories, Irvine, U .K.) buJfered with 
20 mM HEPES and 15 mM sodium bica rbonate, supplemented with 2 mM 
L-glutamine, penicillin, and streptomycin , but not serum . The Petri dishes 
were incubated in air-tight humified chambers aerated with a gas mixture 
(40% 0 2 , 5% C02 , and 55% N 2) at 3 7°C . T he cultures were labeled for 20 h 
with 100 JLCi 35S04 per ml (specific activity, 1000 Ci/mmol) or 5 JLCi 
eHJglucosamine per ml (specific activity, 28 Ci/mmol) or 25 JLCi 
( 14 C] leucine per ml (specific _activity, 35.5 mCi/mmol). All isotopes were 
from The Radiochemical Center, A.mersham (Little C halfont, U.K.). 
Epidermis and dermis were separated for analysis by a brief treatment with 
0.04% ethylenediamine tetraacetic acid at 37°C (Tammi and Tammi, 1986). 
Extraction of CD44 Proteoglycans and CD44 were extracted from the 
tissues with 4 M guanidinium chloride and 0.1 %, 3-((3-cholamidopropyl)-
dimethylammonio]-propane-sulfonate (CHAPS) in 50 mM sodium acetate 
buffer, pH 5.8, in the presence of protease inhibitors (25 mM ethylenedia-
miJ1e tetraacetic acid , 100 mM 6-aminohexanoic acid, 1 mM benzamidine 
hydrochloride , 10 mM N-ethylmaleimide, and l mM phenylmethylsulfonyl 
fluoride) for 24 h at + 4°C as described earlier (Lamberg et nl, 1986; 
M arti kainen et a/, 1992). The tissue residues were pelleted and washed once 
with the extraction buffer. The wash was combined with the extract and 
dialyzed aga inst 4 M urea and 0.1 % SDS, in 40 mM Tris(hydrm.:ymethyl-
)aminomethane (Tris)-acetate buffer, pH 6.8, containing the above protease 
inhibitors, and then 0.1% bovine serum albumin (nuclease and protease free, 
Calbiochem, La Jolla, CA) was added as a carrier. The dialysates were 
divided into portions, each containin g an equal amount of radioacti vity, and 
precipitated overnight at + 4°C in 87'Yo (vol /vo l) ethano l conta ining 45 mM 
soditun acetate. 
Glycosidase Digestions The proteoglycans precipitated with ethanol 
·were redisso lved in a buffer containing 5 111M caJc-iwn nceta te, pJ-I 7 .0 , and 
20% ethanol, and the enzyme inhibitors 10 mM N-ethylmaleimide, 1 mM 
phenylmethylsul fonyl fluoride, and 0.5 mM pepstatin A. The samples were 
treated with heparitinasc [from FlnlloiJncta ium hepnri1111111 , 70 milliunits (mU) 
per ml] , chondroitinasc ABC (from Proteus 1111lgnris, 140 mU per ml), 
keratanasc (from Pscudmuouas sp., 140 mU per ml), keratanase II (from 
Bacillus sp., 476 mU per ml), and endo-{3-galactosidase (from Escheric/1ia 
freumlii , 476 mU per ml). The enzymes were from Seikagaku Kogyo 
(Tokyo, Japan) . The heparitinase, chondroitinase ABC, and keratanase 
digestions were carried out at 3 7"C for 4 h in calcium acetate buffer. The 
endo-{3-galactosidase and keratanase II digestions were carried out in 
sodium acetate buffer, pH 5.8, containing 50 JLg bovine serum albumin per 
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ml and enzyme inhibitors for 16 h. Control s were incubated under the same 
conditions but without enzyme. 
According to the manufitcturer, endo-{3-ga lactosidase cleaves the {31-'>3 
galactosid ic linkages in a polylactosamine or kcratan sul fate chain witl1 tl1e 
repea ting disaccharide structure ({31 --'>4Gal{31-'>3GicNAc].., but only at sites 
where neither the galactose (Gal) nor N-acetylglucosamine (GicNAc) is 
substituted with sulfate residues. Kera tanase cleaves the same {31 -'>3 
galactosidic linkages, but only at sites where N-acetylglucosamine is 
substituted with sulfate at carbon 6, and with a restriction that the adjacent 
ga lactose residue must be nonsulfated. Keratanase II cleaves the f31 -'>4 
linkage of a C6-sulfated N-acetylglucosamine and to lerates sulfate substi-
tution also on the adjacent galactose residue. 
Agarose Gel Electrophoresis The samples were prepared for electro-
phoresis as described above and ana lyzed in submerged 0. 75% or 1.2% 
(wt/ vol) agarose slab gels in a GNA-200 apparatus (Pharmacia, Uppsala, 
Sweden) as desetibed earlier (Saamiinen cl a/, 1989; Martikainen ct nl, 1992) . 
The agarose gels (LE-agarose, SeaKem, FMC Bioproducts, Rockland, ME) 
were prepared in the electrophoresis buJfer (0 .03% SDS, 40 mM Iris-
acetate, and 1 mM Na2S04 , pH 6.8). The electrophoresis was carried out at 
room temperature for 3 h at a 50-mA constant current (38-40 V). 
SDS-PAGE After the enzyme digestions, the samples were concentrated 
by precipitation in 87% (vol/vol) ethanol; dissolved in 47 mM Tris-HCl, pH 
6.8, containing 2% SDS, 1 mM Na2S04 , and 0.03% bromphenol blue; and 
boiled for 4 min . In some of the samples, mercaptoetl1anol (5%, vol/vo l) 
was included. The samples were electrophoresed in a MiniProtean II 
electrophoresis cell with 4 - 15% gradient SDS-polyacrylamide gels (Bio-
Rad Laboratories, Hercules, CA. Prelabeled protein standa.rds (Rainbow 
markers, Amersham, and Multimark, NOVEX, San Diego, CA) were used 
for molecular mass calibration . 
lmmunoprecipitation For inmmnoprec1p1tation, 35S04-labeled or 
[ 14C]leucine-labeled ethanol-precipitated samples were dissolved in the 
immunoprecipita tion buffer (0.1 % SDS, 0.1% 3-((3-cholamidopropyl)-di-
methylammonio ]-propane-sulfonate, 25 mM sodium phosphate buffer, pH 
7.4). Bovine serum albumin was added to a final concentration of0.5 mg 
per mi. To exclude unspecific adsorption, 500 JLl of the mixture were 
combined w ith 40 JLl of 50'Yo protein A-Sepharose CL-4B (Pharmacia , 
Uppsala, Sweden) in phosphate-buffered saline and incubated for 30 min. 
The pellet was removed with centrifugation, and the supernatants were 
mixed with another 40-!Ll portion of protein A-Sepharose, preincubated 
with Hermes-3 antibody (undiluted hybridoma supematant, a gift from Dr. 
Sirpa Ja1kanen, Turku, Finland) ovemight at 4°C. After 20 h of end-to-end 
shaking, the suspensions were centrifuged , and the pellets were washed 
twice with the immunoprecipitation buffer and three times with 0.1 M 
Tris-HCl, 0.15 M NaCl , and 0.1% 3-((3-cholamidopropyl)-dimethylammo-
nio]-propane-su lfonate, pH 7.4. T he samples were divided into equal 
portions, dispersed in 5 mM calcium acetate, pH 7 .0, and the enzyme 
inhibitors, and digested with the glycosidases as described above. After the 
digestions the samples were pelleted and boiled in the electrophoresis buJfer. 
They were then ana lyzed by SDS-PAGE or by agarose gel electrophoresis as 
described above. T he gels were fixed and processed for autoradiography 
and exposed on H yper-beta-Max film (Amersham) at -80°C as described 
earlie r (Martikainen c/ nl, 1992) . For fluorography, the gels were immersed 
in 2,5 di-phenyloxazole (Bonner and Laskey, 1974; Laskey cl nl , 1977) and 
dried . 35504-labeled samples were exposed to untreated Hyperfilm MP 
(Amersham) at room temperature and 1"1C-labeled samples were exposed to 
preflashed H yperfilm MP at - 80°C. 
Western Blotting T he gels were blotted onto polyvinylidine fluoride 
membranes (MiJlipore, Bedford , MA) by using a semi-dry blotting appara-
tus (Pegasus, PI-lASE, Miiln, Gern1any). Mter blocking nonspecific binding 
with 5% nonfat milk powder in phosphate-buffered sa line/0.05% Tween 20 
buffer, the sheets were inc ubate d overnight at +4°C with Hcn11cs 3 
antibody, diluted to 2 JLg per ml in the blocking buffer, fo llowed by 
peroxidase-labeled anti-mouse lgG (P0447, Dako, Glostrup, Denmark, 
1:1000 dilution in 1'!/o nonfat milk powder in phosphate-buffered sa line/ 
Tween) for 1 h at room temperature. The sheets were washed for a 15-min 
period and for four 5-min periods with the phosphate-buffered saline/ 
Tween between the different steps. D etection with the chemiluminescence 
system was done according to manufacturer's instructions (western blot 
chemiluminescence reagent, NEN DuPont Research Products, Boston, 
MA). N egative control s included samples where the primary antibody was 
replaced with nonimmuJ1C lgG (lgG2a, Sigma, St. Louis, MO) or was 
completely omitted. 
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Figure 1. CD44 forms the low mobility end of epidermal proteo-
glycans in agarose gel electrophoresis. 35S04-Iabelcd proteoglycans 
extracted from human epidermis were separated by 0. 75% aga.rose electro-
phoresis with 0.03"/(, SDS. Lanes from left show total 35S0 4-labclcd 
proteoglycans (Tot PG) , 35S04-Iabeled immunoprecipitate with Hennes 3 
(H 3), and 35S0 4-labeled supernatant after inununoprecipitation with 
Hermes 3 (H 3 sup) . The migration positions of calf articular cartilage 
aggrccan (Al-PG) and standard chondroitin sul fa te (CS) are shown. 
RESULTS 
CD44 Antibody Immunoprecipitates a Significant Propor-
tion of Total Epidermal Proteoglycans Tissue explants were 
incubated for 20 h with (35S04 ) , [' 4 C )leucine, or [3 H)glucosamine 
in whole skin organ culture to label epidermal proteins and 
proteoglycans . Epidermal sheets were then extracted with 4 M 
guanidinium chloride, including de tergent and a proteinase inhib-
itor mixture. We have shown previously that this isolation method 
recovers more than 90'X, of epidermal proteoglycans (Martikainen ef 
al, 1992). Each extract was dialyzed against 4 M urea and 0.1 % SDS 
to remove sulfated lipids (Martikainen et a/, 1992) . The extracts 
were concentrated by ethanol precipitation, dissolved , and electro-
phoresed for direct western blotting or subjected to immunopre-
cipitation. Immunoprecipitation oe5 S04 -labeled samples with the 
monoclonal Hermes 3 antibody, which recognizes an epitope 
present in all CD44 forms, brought down 9.4 :±: 2 .8% (range 
7-17%, n = 7) of all radio labeled proteoglycan in epidermis after a 
24-h labeling. The immunoprecipitated CD44 was one of the 
slowest migra ting epidermal proteoglycan species in agarose gel 
electrophoresis (Fig 1). 
Heparan Sulfate and Endo- /3- galactosidase- Sensitive Oli-
g o saccharides Are the Major Carbohydrate Substituents on 
Epidermal CD44 Substitution of the epidermal CD44 with 
different glycosaminoglycans was probed with enzymes specific for 
heparan sulfate, chondroitin sulfate, keratan sulfate, and polylac-
tosamine, a homolog of keratan sulfate with little or no sulfate 
residues. Epidermal samples were metabolically labeled in organ 
culture either with 35SO 4 or eHJglucosamine and purified by 
immunoprecipitation with Hermes 3. Table I summarizes the 
enzymatic release of the incorporated 35S0 4 - and [3 H]glucosamine 
from the immunoprecipitates. Heparitinase re leased on th e 
average 54% of sulfate and 33% of glucosamin e, and chondroiti-
nase released 15% and 9%, respectively, indicatin g that heparan 
sulfate was the major sulfated glycosaminoglyca11 in epidermal 
CD44. Keratanase released less than 5% of both isotopes from 
the precipitates, and endo-J3- galactosidase rel eased 13% and 32% 
of 35S and 3 H, resp ectively (Table 1). According to the content 
of incorporated [3 H]glucosami.ne, endo- J3-gala ctosid ase- sensi-
tive c hains were thus almost as abundant as heparan sulfate in 
ep iderma l CD44 . 
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Table I. Epidermal CD44 Contains Substituents 
Sensitive to Heparitinase, Chondroitinase ABC, and 
Endo-{3-galactosidase" 
Radioactivity Released (%) 
Enzyme 
Hcparitinase 
Chondroit.inase ABC 
Keratanase 
Endo-(3-galactosidase 
54 (40 - 68) 
15 (::'::9) 
3 (0-5) 
l3 (::'::6) 
eH]Glucosamine 
33 (24-40) 
9 (6-12) 
2 (0-5) 
32 (::'::6) 
" Sensitivity of epidermal CD44 to glycosaminoglycan-dcgrading enzym es was 
studied by digesting the immunoprecipitates as described in NJaterials a11d t\tletlwds a.nd 
expressed as a percentage released into the digestion buffer of the total activity in the 
imnnmoprccipirate. The experiments included skin fro m eigh t different donors, two to 
five experiments were don e on 3 5S0.1-labclcd samples with each enzyme and two or 
three experiments were don e o n [3 H] glucosaminc-lnbcled sa mples. T he figures in 
parenthesis are ± SO: range of the determinations is shown when the mean was 
calculated from only two don ors. 
Ren1oval of Heparan Sulfate Retards and Removal of 
Endo- /3- galactosidase- Sensitive Oligosaccharides En-
hances the Mobility of Epidermal CD44 on Agarose Gel 
Electrophoresis In agarose gel electrophoresis under nonreduc-
ing conditions, most of the [' 4 C ]leucine- and 35SO 4- labeled immu-
noprecipitated epidermal CD44 moved as a broad band with an 
apparent size of 2: 180 k.Da (Fig 2a,b) , suggesting extensive 
a b c 
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LA III IDJJI" f\UJ I 
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L .. Ali i l 111111' !ill I 
1:4 Jj\[l Cll"''" J\ll II 
200 90 69 200 90 69 
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200 90 69 
Figure 2. Hcparitinase and endo-{3-galactosidase have opposite 
effects on the mobility of epidermal CD44 in agarose gel electro-
phoresis. The samples were extracted and purified as described in Mnrerinls 
n111/ Methods and analyzed on 1.2'X. agarose containi11g 0.03% SDS. Densi-
tometric tracings of Hermes 3 immunoprecipitates digested with different 
enzymes prior to electrophoresis are shown. (a) [' ''C]lcucine-labeled sam-
ples. (b) 35S04- labcled samples. (c) T racings of wes tern blots. The parts are 
labeled as follows: C, no treatment; H, heparitinase; Ch, chondroitinase 
ABC; K, keratanase; E, endo-{3-galactosidase. T he positions of protein 
standards (200-kDa myosin, 98-kDa phosphorylase b, and 69-kDa bovine 
scrun1 albun1in) a.re indicated . 
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Figure 3. Epidermis has three major forms ofCD44 in SDS-PAGE, 
with variable glycosylation. Westem blot analysis with Hermes 3 
antibody was done from epidermal CD44 extracted and purified as de-
scribed in Mnte1ials and Methods and subjected to degradation with enzymes 
prior to SDS-PAGE. The positions of protein standards (250, 148, 69, and 
42 kDa) are indicated. Lane C, control, buffer only; /nne H, heparitinase; lane 
Ch, chondroit:inase ABC; lane K, keratanase; lane H +Ch, beparitinase and 
chondroitinase ABC; la11e H+Ch+K, heparitinase , chondroiti.nase ABC, 
and keratanase; laoe E, endo-/3-galactosidase. SDS-PAGE was performed 
under non.reducing conditions in (a) and in reducing conditions in (b). 
heterogeneity of the protein(s) or their glycosylation. Most of the 
35504-label was removed by heparitinase (Fig 2b). A paradoxical 
slower mobility was observed in [' 4 C]leucine- and 35504-labeled 
epidermal CD44 after beparitinase digestion, and a similar shift was 
observed in western blots (Fig 2a-c). The retardation in agarose 
electrophoresis was observed consistently when the samples were 
digested with beparitinase, either alone or in combination with 
other enzymes (Fig 2c) . The open structure of the agarose makes 
tbe migration relatively more dependent on charge as compared to 
size. Removal ofheparan sulfate, the major charged component of 
the molecule, apparently retarded the electrophoretic migration of 
epidermal CD44. 
Digestion with chondroitinase and keratanase had no detectable 
effect on the mobility proftle of 35504 activity in agarose, due to 
their small proportion of all glycosaminoglycans (Fig 2a- c). Endo-
,13-galactosidase considerably increased the mobility but had a minor 
effect on the sulfate content (Fig 2a.,b) . Tl:lls was anticipated 
because the endo-,13-galactosidase sensitive chains had relatively 
more contribution to the size and perhaps conformation of tbe 
molecule than to its charge. 
A w estern blot of the intact and digested CD44 demonstrated a 
mobility similar to the immunoprecipitates (Fig 2a-c). The western 
blot analysis confirmed the specificity of the immnnoprecipitation 
and suggested that the high molecular weight CD44 is the most 
abundant species of CD44 in the epidermal tissue. 
Heparitinase Treatment Reduces the Molecular Weight of 
the Large Epidermal CD44 from ~250 to 180-200 kDa on 
SDS-PAGE Com.plementary western blots and immtmoprecipi-
tations were done on SDS-PAGE, wl:llch separates small molecules 
with more resolution and exhibits molecular weight and charge 
selectivity different from agarose. The epidermal CD44 detected by 
western blot analysis after SDS-PAGE was resolved in three main 
bands (Fig 3). Under nomeducing conditions, the molecular masses, 
in an order of decreasing band intensity, were 2:250 kDa, 100 kDa, 
and 180 kDa (Fig 3a, lane q , and after reduction the molecular masses 
were 2::250 kDa, 110 kDa, and 210 kDa, respectively (Fig 3b, lane q . 
The ba11ds at 68 and 80 kDa (Fig 3a,b) were nonspecific because they 
were recogt:llzed by noninmmne IgG. 
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Western blot analysis indicated that most, if not all of the 
hepara11 sulfate resided in the 2::250- kDa smear, because the signal 
shifted to 180-220 kDa after heparitinase digestion (Fig 3a,b, lane 
I-f). There was also a little chondroitin sulfate-substituted CD44 
with a core molecule appearing at 100 kDa after chondroitinase 
ABC, and perhaps originating around 250 kDa, because chondroiti-
nase ABC reduced the signal left at this area after heparitinase (Fig 
3a,b, Innes H+ Ch) . Keratanase alone had little influence. 
35$04- labeled immunoprectpttes subjected to SDS-PAGE 
showed the majority of the activity at 2::250 kDa, although less label 
was present at 180 kDa and below (Fig 4, panels q. Digestion with 
heparitinase removed the 35$04 -label at 2:: 250 kDa, and most of 
the remaining activity now appeared at 180 kDa (Fig 4, Innes C,H). 
Digestion with chondroitinase ABC caused a minor average mo-
bility increase in the 35504-label of the 2::250-kDa band, whereas 
keratanase and keratanase II did not cause a notable change (Fig 4, 
lanes C,K,KII). In endo-,13-galactosidase digested samples the activ-
ity at 2:: 250 kDa moved ahead, with a broader peak tailing to lower 
molecular weight (Fig 4, la1-tes C,E). 
Some of the Small (100-110 Iilla) Epidermal CD44 Are 
Substituted with Chondroitinase ABC- and Endo-,13-galac-
tosidase-Sensitive Chains The band at 100/110 kDa (nonre-
duced/reduced samples) was always present in the western blots 
from SDS-PAGE gels, but not significantly labeled with 35$04 or 
c 
H E 
250 148 
Figure 4. 35S04 -labeled epidermal CD44 shows reduced size in 
SDS-PAGE after heparitinase, chondroitinase ABC, and endo-13-
galactosidase . The densitometric tracings from fluorographs of 35$0,1-
labelcd Hermes 3 immunoprecipitates on SDS-PAGE (without reduction) 
originate from two experiments, each shown as a column of panels . 
Labeling, extraction, purification, aud enzyme treatments were done as 
described in Materials a11d Methods. Labels for the treatments are as follows: 
C, no treatment; H, hepariti.nase; Ch, chondroitinase ABC; K, keratanasc; 
E, endo-/3-galactosidase; !<II, kera tanase II. The migration positions of250-
and 148-kDa molecular weight markers arc shown. 
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shifted in position after enzyme treatment (Fig 3a,IJ). The density 
of the band at tlus position was increased after chondroitinase ABC 
(Fig 3a.,IJ, lanes Ch,H+ Ch,H+ Ch+ K) and endo-{3-galactosidase 
digestions (Fig 3b, la11e E) , suggesting that a part of this form 
carried chondroitinase ABC- and endo-{3-galactosidase- sensitive 
chains. Keratanase (Fig 2a,IJ, laue K) and keratanase II (data not 
shown) did not enhance the signal at 100/110 kDa, indicating that 
the substituents did not conform to the structure of keratan sul fate. 
The original migration position of the endo-{3-galactosidase-sensi-
tive material could not be positively identified but may start as 
diffuse signal immediately behind the 100/11 0-kDa band (Fig 21J). 
DISCUSSION 
In the current study we show that the major form of CD44 
expressed in normal adult human epidermal tissue is a 2:250-kDa 
molecule substituted with heparan sulfate and endo-{3-galactosi-
dase-sensitive oligosaccharides. Its abundance, more than 9% of all 
newly synthesized 35S04-labeled proteoglycans, suggests that it has 
an important role in tlus epithelium. Tlus large CD44 presumably 
corresponds to that previously observed in human keratinocyte cell 
cultures (epican, with exons v3-v10) (Haggerty eta/, 1992; Hudson 
et al, 1995) and present as the v3-positive immunostaining compo-
nent throughout the vital epidermal layers (Seelentag et al, 1996). 
There was also a less-abundant smaller CD44 of about 100 kDa, 
a probable match of the hemopoietic CD44s, although it appears 
larger than the CD44 on fibroblasts (90 kDa; Hudson et al, 1995) 
and observed in the dermal tissue (93 kDa, Tuhkanen, unpublished 
data). In a contrast to previous studies in keratinocyte cell cultures, 
a significant proportion of the small CD44 in epidermal tissue was 
substituted with chondroitin sulfate or chains sensitive to endo-{3-
galactosidase. At least a part of the CD44s can originate from 
melanocytes that are about 10% as abundant as basal cells and 
display electron microscopic immw1olabeling density for CD44 
equal to that in keratinocytes (Tuhkanen A-L, Tammi M, Pelttari 
A, Agren UM, Tamnu R, unpublished results). Epidermal melano-
cyte cultures e"'Press 85-kDa and > 200-kDa forms of CD44 
(Herbold et a/, 1996). The > 200-kDa form is substituted with 
chondroitin sulfate. Both have CD44s, without any variant exons, 
as a core protein (Herbold eta/, 1996). 
The importance of the endo-{3-galactosidase-sensitive oligosac-
cha.rides is stressed by the fact that in total 3 H-labeled material, they 
almost equalled heparan sulfate. Linkages susceptible for endo-{3-
galactosidase typically e"-ist in polylactosam.ine and keratan sulfate, 
its sulfated form. Epidermal CD44 was resistant to keratanase and 
keratanase II, w lu.ch cleave bonds adjacent to a 6-su lfated N-
acetylglucosamine in a polylactosamine core, whereas endo-{3-
galactosidase requires a galactose {31--,)4 bonded to a nonsulfated 
N-acetylglucosamine. T lus suggests that polylactosamine on epi-
dermal CD44 has little sulfate or the sulf.'lte is bonded to structures 
other than the N-acetylglucosamine in the repeat region. An 
immunolustochemical signal for low sulfated kerata.n sulfate was 
reported on human keratinocyte plasma membranes (Sorrell et al, 
1990). Interestingly, polylactosanune is a potential ca.rrier of the 
blood group H antigen, present on CD44 and correlates with the 
invasive potential of colon carcinoma cells (Labarriere et al, 1994). 
As far as we know, the presence of polylactosanune on CD44 has 
not been probed before using endo-{3-galactosidase digestion. 
Recent studies indicate that certain variants of CD44 contain 
sulfate in 0-glycosidically linked oligosaccharides (Lokeshwar et nl, 
1996) that are susceptible to kerata.nase (Takahaslu eta/, 1996) . The 
polylactosarnine we find in epidermal CD44 may correspond to the 
0-li.nked keratan sulfate in other cells, because developmental 
regulation occurs in polylactosamine chain length and sulfation 
(Plaas and Wong-Palms, 1993). The current data do not allow 
distinction between N- and 0-linkages, however. The membrane 
proxin1al domain of CD44, and the variant exons in particular, 
contain a large proportion of hydrophilic an1.ino acids (Kugelman et 
a/,1992), especially serine and threonine (Screaton et al, 1992). 
Serine and threonine can be utilized for the addition of mucin-like 
oligosaccharides (Hudson eta/, 1995; Lokeshwar eta/, 1996), some 
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of wluch may w1dergo extension into polylactosanune or keratan 
sulfate (Lohmander et al, 1980; Takahashi ef a/, 1996). 
The elimination of the polylactosanune from the large ep idermal 
CD44 caused a dramatic enhancement in its mobility in agarose 
electrophoresis . Removal of the less su.lfated carbohydrate chains 
would increase charge/mass ratio and allow lugher mobility. A 
conformational change of the protein may occur that may be 
functionally significant. The membrane proximal region including 
the variant exons, rich in 0-glycosylation, was proposed to con-
fonn to a rod about 60 nm long Qackson et a/, 1995) . Keratanase 
treatment (Takahaslu et al, 1996) or blocked 0 -glycosylation with 
phenyl-a-N-acetylgalactosaminide (Bennett et al , 1996) stimulated 
hyaluronan binding, but elimination of N-glycosylation inhibited 
hyaluronan affinity of CD44 (Bartolazzi et nl, 1996). Altered 
conformation was suggested to be responsible for these effects . The 
removal of the polylactosamine chains may have disrupted the rod 
shape and resulted in the altered mobility fow1d in agarose electro-
phoresis. 
Hyaluronan exists in high concentrations in the intercellular 
space of epidernus (Tammi et al, 1994) and is closely colocalized 
with CD44 (Wang eta/, 1992) . The affinity of the epidermal CD44 
for hyaluronan cam1ot be esti.mated in the current experimental 
system but, as discussed above, extrapolation of the data available 
on various cell cultures indicates that although binding exists 
(Mi.lstone et al, 1994), it is perhaps relatively weak. Even a low 
binding constant, however, would lead to sigtuficant interaction 
due to the abundance of CD44 and the !ugh concentration of 
hyaluronan in the limited space between keratinocytes. In fact a 
loose adherence might facilitate the migration and cell shape 
changes required in the stratification and differentiation processes. 
CD44 can modulate cell -cell interactions either by homotypic 
aggregation, or by binding to hyaluronan (Milstone et al, 1994; 
Hudson et nl, 1995). In normal epidermis, CD44 is preferentially 
localized on microvilli iliat intermingle in the intercellular space, 
whereas close contact sites such as desmosomes and the interface to 
basal la.nuna contain no CD44 (Tuhkanen A-L, Tan1mi M, Peltta.ri 
A, Agren UM, Ta.nuni R, unpublished results). The hyaluronan in 
the extracellular space may cross-bridge two keratinocytes through 
CD44 anchors on both sides and provide epidermis with its 
controlled extracellular space. TIJ.is idea is supported by our 
pre.liminary experiments that hyaluronidase treatment of the organ 
culture opens up the extracellulru· spaces, i.e. , causes acanthosis 
(Agren UM, Tammi M, Tammi R, unpublished fi ndings) . Acat1-
thosis and disappearance of CD44 both occur around leukocytes 
nugrating in epidernus (Tammi et a/, 1994), suggesting that the 
invading cells make room for migration by inducing d1e removal of 
CD44 and the associated hyaluronan. 
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